| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
|---|
|
Total Revenue
|
44,633,000
|
38,245,000
|
34,501,000
|
31,487,000
| | Cost of Revenue | 24,872,000 | 22,473,000 | 19,485,000 | 17,255,000 | | |
Gross Profit
|
19,761,000
|
15,773,000
|
15,015,000
|
14,232,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 37,658,000 | 33,359,000 | 28,729,000 | 25,857,000 | | | |
Operating Income or Loss
|
6,975,000
|
4,886,000
|
5,772,000
|
5,631,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 6,975,000 | 4,886,000 | 5,772,000 | 5,631,000 |
|
Interest Expense | (981,000) | (1,018,000) | (913,000) | (583,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 1,833,000 | 828,000 | 901,000 | 794,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 4,276,000 | 2,993,000 | 4,002,000 | 4,242,000 | |
|
Non-recurring Events |
|
Discontinued Operations | (882,000) | (364,000) | (939,000) | (1,424,000) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
3,395,000
|
2,365,000
|
2,794,000
|
2,728,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.14%